^
BIOMARKER:

IGH mutation

i
Other names: IGH, Immunoglobulin Heavy Locus, Immunoglobulin Heavy Polypeptide, Joining Region, Immunglobulin Heavy Chain Variable Region, Immunoglobulin Heavy Diversity Cluster, Immunoglobulin Heavy Variable Cluster, D (Diversity) Region Of Heavy Chains, Immunoglobulin Heavy Diversity Group, Immunoglobulin Heavy Diversity Locus, Immunoglobulin Heavy Joining Cluster, Immunoglobulin Heavy Variable Group, J (Joining) Region Of Heavy Chains, Immunoglobulin Heavy Joining Group, Immunglobulin Heavy Chain, IGH.1@,
Entrez ID:
Related biomarkers:
IGH mutation
CLL
ibrutinib
Sensitive: A2 - Guideline
IGH mutation
CLL
obinutuzumab
Sensitive: A2 - Guideline
IGH mutation
CLL
venetoclax + obinutuzumab
Sensitive: A2 - Guideline
IGH mutation
CLL
FCR
Sensitive: A2 - Guideline
IGH mutation
Small Lymphocytic Lymphoma
ibrutinib
Sensitive: B - Late Trials
IGH mutation
CLL
rituximab + idelalisib
Sensitive: B - Late Trials
IGH mutation
Small Lymphocytic Lymphoma
FCR
Sensitive: C3 – Early Trials
IGH mutation
CLL
iFCG
Sensitive: C3 – Early Trials